Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam

Amy D Robertson1,2, Chenghui Li3, Drayton A Hammond4

  • 1Department of Pharmacy Practice, University of Arkansas for Medical Sciences Northwest Regional Campus, Fayetteville, Arkansas.

Pharmacotherapy
|September 4, 2018
PubMed
Abstract

Insights

Vancomycin combined with piperacillin-tazobactam (PTZ) significantly increases acute kidney injury (AKI) risk compared to vancomycin with meropenem (MER). This finding is crucial for managing infections and preventing kidney damage in acutely ill patients.

Area of Science:

  • Nephrology and Infectious Diseases
  • Clinical Pharmacology and Therapeutics

Background:

  • Vancomycin (VAN) use is linked to acute kidney injury (AKI).
  • Conflicting evidence exists regarding the AKI risk when VAN is combined with antipseudomonal β-lactams.

Purpose of the Study:

  • To compare the incidence of AKI in acutely ill adults receiving VAN combined with piperacillin-tazobactam (PTZ) versus meropenem (MER).

Main Methods:

  • Retrospective cohort study of 169 adult patients receiving VAN/PTZ or VAN/MER for ≥48 hours.
  • Exclusion of critically ill patients and those with baseline renal dysfunction.
  • Primary outcome: AKI incidence defined by serum creatinine increase; secondary outcomes: time to AKI, duration, and hospitalization length.

Main Results:

  • AKI incidence was significantly higher with VAN/PTZ (16.5%) compared to VAN/MER (3.6%).
  • Time to AKI onset was shorter with VAN/PTZ (3 days) versus VAN/MER (7 days).
  • VAN/PTZ was associated with a 6.8-fold increased risk of AKI after adjustment.

Conclusions:

  • The combination of VAN/PTZ increases the risk of AKI compared to VAN/MER in acutely ill adults.
  • High VAN doses (>4 g/day) and trough levels (>20 μg/ml) were independent risk factors for AKI.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
756
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
481
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
362
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
950
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
341